Developed the first FDA-cleared digital therapeutic that significantly reduces/eliminates symptoms of panic attacks & PTSD in only 28 days
Freespira, Inc. has raised $22.6M in total funding. The most recent round was Series E. The last funding was announced in April 2024.
Freespira, Inc.'s investors include Lightspeed Venture Partners, Kleiner Perkins, Farzad Nazem.
Freespira, Inc. is headquartered in Kirkland, United States.
Developed the first FDA-cleared digital therapeutic that significantly reduces/eliminates symptoms of panic attacks & PTSD in only 28 days
Freespira, Inc. is at the Series E stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Freespira, Inc. — Funding & Investors." VCBacked, April 15, 2024, https://www.vcbacked.co/company/freespira-inc. Accessed July 19, 2026.
VCBacked. (2024). Freespira, Inc. — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/freespira-inc
{{cite web |title=Freespira, Inc. — Funding & Investors |url=https://www.vcbacked.co/company/freespira-inc |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated